Skip to main content
main-content

18-05-2022 | Oncology | Video

ELCC 2022 | Perioperative immunotherapy for NSCLC: Perspectives from an oncologist and a surgeon

Martin Reck and Hans Hoffmann discuss the optimal clinical trial endpoints and patient selection for neoadjuvant and adjuvant immunotherapy for resectable non-small-cell lung cancer (14:58).